Risk analysis of gastrointestinal bleeding in hospital patients with acute myocardial infarction undergoing primary PCI

[1] Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018; 39: 213−260. doi: 10.1093/eurheartj/ehx419 [2] Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2020; 41: 3495−3497. doi: 10.1093/eurheartj/ehaa624 [3] Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006; 114: 774−782. doi: 10.1161/CIRCULATIONAHA.106.612812 [4] Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021; 42: 1289−1367. doi: 10.1093/eurheartj/ehaa575 [5] Sehested TSG, Carlson N, Hansen PW, et al. Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction. Eur Heart J 2019; 40: 1963−1970. doi: 10.1093/eurheartj/ehz104 [6] Kim BK, Hong SJ, Cho YH, et al. Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial. JAMA 2020; 323: 2407−2416. doi: 10.1001/jama.2020.7580 [7] Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol 2017; 112: 212−239. doi: 10.1038/ajg.2016.563 [8] Issa M, Alqahtani F, Berzingi C, et al. Impact of acute diabetes decompensation on outcomes of diabetic patients admitted with ST-elevation myocardial infarction. Diabetol Metab Syndr 2018; 10: 57. doi: 10.1186/s13098-018-0357-y [9] Albeiruti R, Chaudhary F, Alqahtani F, et al. Incidence, predictors, and outcomes of gastrointestinal bleeding in patients admitted with ST-elevation myocardial infarction. Am J Cardiol 2019; 124: 343−348. doi: 10.1016/j.amjcard.2019.05.008 [10]

Thomas MP, Bates ER. Update on primary PCI for patients with STEMI. Trends Cardiovasc Med 2016; 27: 95−102.

[11]

Stone GW, Selker HP, Thiele H, et al. Relationship between infarct size and outcomes following primary PCI. J Am Coll Cardiol 2016; 67: 1674−1683.

[12] Sarajlic P, Simonsson M, Jernberg T, et al. Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study. Eur Heart J Cardiovasc Pharmacother 2022; 8: 483−491. doi: 10.1093/ehjcvp/pvab059 [13] Patel NJ, Pau D, Nalluri N, et al. Temporal trends, predictors, and outcomes of in hospital gastrointestinal bleeding associated with percutaneous coronary intervention. Am J Cardiol 2016; 118: 1150−1157. doi: 10.1016/j.amjcard.2016.07.025 [14] Wärme J, Sundqvist M, Mars K, et al. Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction. Am Heart J 2021; 231: 105−109. doi: 10.1016/j.ahj.2020.10.072 [15]

Mladenova I. Helicobacter pylori and cardiovascular disease: update 2019. Minerva Cardioangiol 2019; 67: 425−432.

[16] Elesebaey MA, Tawfik MA, Ezzat S, et al. Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actibely bleeding esophageal varices: a randomized controlled trial. BMC Gastroenterol 2019; 19: 23. doi: 10.1186/s12876-019-0940-1 [17]

Song YB, Li JB, Bian SZ, et al. Association between low free triiodothyronine levels and poor prognosis in patients with acute ST-elevation myocardial infarction. Biomed Res Int 2018; 2018: 9803851.

[18]

Razvi S, Jabbar A, Bano A, et al. Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction. Eur Thyroid J 2022; 11: e210085.

[19] Zhang K, Tang YD, Zhang Y, et al. Comparison of therapeutic triiodothyronine versus metoprolol in the treatment of myocardial infarction in rats. Thyroid 2018; 28: 799−810. doi: 10.1089/thy.2017.0544 [20] WANG JY, LIU DW, XIE Y. Association between Helicobacter pylori infection and serum thyroid stimulating hormone in the National Health and Nutrition Examination Survey 1999-2000. Front Endocrinol (Lausanne) 2022; 13: 1018267. doi: 10.3389/fendo.2022.1018267

留言 (0)

沒有登入
gif